Clever Culture Says Novo Nordisk to Assess Its APAS Technology for Use Across Manufacturing Network

MT Newswires Live
2025/07/14

Clever Culture Systems (ASX:CC5) said it received a purchase order for an APAS Independence instrument from Novo Nordisk in Europe, and the Danish firm will assess the suitability of the technology for use across their manufacturing network, according to a Monday Australian bourse filing.

The evaluation will assess the performance of both 90 millimeter and contact plate analysis modules for the reading of culture plates used in pharmaceutical environmental monitoring.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10